Viewing nowSitagliptin Alpha 100 mg Tablet (Sitagliptin Hydrochloride Hydrate)
Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daehan New Pharm Co., Ltd.

MFDS item code 202004067 · Approved 2020.05.29 · Insurance code 669907990
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used along with diet and exercise therapy to assist patients with type 2 diabetes in controlling blood sugar levels. It can be used alone, and for those starting treatment who have difficulty controlling blood sugar with monotherapy, it may be used in combination with metformin. Additionally, it is recommended to take this medication when blood sugar control is insufficient, even when using sulfonylureas, metformin, thiazolidinediones, or insulin alone. This medication helps manage blood sugar effectively in conjunction with multiple treatment methods. Therefore, it is used to improve blood sugar control in patients.
This drug is administered once daily at a dose of 100 mg as monotherapy or in combination therapy, and the maximum daily dose is 100 mg. This drug may be taken with or without food. When administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see section 5. General Precautions, under Precautions for Use). Patients with renal impairment Since dosage adjustment is required according to renal function, evaluation of renal function is recommended before treatment with this drug and periodically thereafter. 1. No dosage adjustment is necessary in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is necessary in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. In patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. 4. In patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This drug may be administered regardless of the timing of dialysis.
This medication may rarely cause serious allergic reactions; thus, if symptoms such as rash, difficulty breathing, or swelling of the face or neck occur within three months of administration, the medication should be stopped immediately and a doctor consulted. This medication has been reported to cause serious side effects, such as pancreatitis, which is inflammation of the pancreas; therefore, if symptoms like abdominal pain, vomiting, or loss of appetite occur during treatment, medical personnel should be informed immediately. Patients with type 1 diabetes, diabetic ketoacidosis, or those allergic to this medication or its components should not take it. Patients with reduced kidney function need adjustments in the dosage of this medication; therefore, it is important to have kidney function tests before and during treatment. Mild side effects such as upper respiratory infections, nasopharyngitis, headaches, diarrhea, nausea, constipation, muscle pain, limb pain, back pain, itching, thrombocytopenia, indigestion, dizziness, increased triglycerides in the blood, gastritis, weight loss, hypertension, hypernatremia, and erectile dysfunction may occur during the use of this medication, but most are temporary. When taken with other hypoglycemic agents, especially insulin or sulfonylureas, the risk of hypoglycemia may increase; therefore, careful monitoring of blood sugar levels is required. If severe joint pain or blistering skin symptoms occur, the doctor should be informed immediately, and medication may need to be discontinued if necessary. Pregnant or planning to become pregnant women, nursing women, and children under 18 years old should not use this medication as its safety has not been established. Elderly individuals should monitor kidney function and adjust the dosage for safe use as decreased kidney function is common in this population. In the event of an overdose, immediate medical attention is required, and this medication can be partially removed by hemodialysis. This medication has a low risk of interactions with other drugs; however, monitoring blood levels of digoxin is advisable when used concurrently.
Severe hypersensitivity reaction, anaphylaxis, angioedema, Stevens-Johnson syndrome, exfoliative skin disease, acute pancreatitis, hypoglycemia, upper respiratory infection, nasopharyngitis, headache, diarrhea, abdominal pain, nausea, constipation, vomiting, arthralgia with severe and debilitating symptoms, vesicular bullous pemphigoid, myalgia, limb pain, back pain, interstitial lung disease, pruritus, thrombocytopenia, rhabdomyolysis, elevated liver enzymes, acute renal failure, pneumonia, diabetic complications, metabolic acidosis, falls, cardiac arrest, dyspepsia, dizziness, increased blood triglycerides, gastritis, increased blood triglycerides, increased low-density lipoprotein, hyperglycemia, weight loss, hypertension, hypernatremia, erectile dysfunction
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to prevent exposure to air or moisture. It is also important to maintain a normal room temperature between 1 and 30 degrees Celsius when storing the medication.
Light orange, round, bilayer film-coated tablet
30 tablets/box [10 tablets/PTP×3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daehan New Pharm Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.